1 terminated, 1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow ARC-AAT Injection: new trials by email Literature Review of ARC-AAT Injection trials Research Report on ARC-AAT Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels ARC-AAT Injection - Alpha-1 Antitrypsin Deficiency | Phase 2 | Withdrawn | Arrowhead Pharmaceuticals | 2016-10-01 | 2025-12-18 | |
| A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD) ARC-AAT Injection, Placebo, Diphenhydramine - Alpha-1 Antitrypsin Deficiency | Phase 1 | Terminated | Arrowhead Pharmaceuticals | 65 | 2015-02-01 | 2026-01-12 |
alpha 1-Antitrypsin Deficiency (2)
Australia (1) · Canada (1) · Germany (1) · Ireland (1) · Italy (1) · Netherlands (1) · Sweden (1) · United Kingdom (1)
2015 (1), 2016 (1)